* Joint PhD in Engineering and Medical Science with a strong technical background in biochemical engineering, manufacturing process development, analytical test development, molecular biology, and biochemistry. * Over 20 years combined industry experience in a scientific leadership role as a VP/ Senior Director/ Global Director/Head in Research and Development in both small biotech and large biopharma environments. * Broad experience in different aspects of vaccine and therapeutic development including mRNA-LNP, subunit and live viral vaccines, mAbs, animal cell culture, antibody technology, diagnostics, recombinant protein expression and purification, molecular biology, Piggybac transposon technology, baculovirus-insect cell culture, bacterial expression, virology, bioreactor operation and scale-up, assay development, product formulation and stability, bioinformatics, and proteomics. * Strong understanding of CMC regulatory requirements for vaccines and therapeutics and authored numerous strategy documents (manufacturing, analytical, impurities, troubleshooting), journal publications, risk assessments for different CMC elements, QBD approaches, comparability reports, technical documents, prepared entire CMC DS and DP sections for regulatory submissions (IND, FDA, CTD) as well as IB contributions and briefing packages. * Considerable experience in technology transfer and outsourcing of material manufacture by CDMOs (live virus, mRNA, LNP, plasmid, recombinant protein, antibodies, virus, diagnostic kit manufacture), process validation, and corresponding analytical test development and QC. * Five years as a university academic with collaborators in cancer research, infectious diseases, parasitology, and engineering. Developed DNA-protein expression vectors using transformed cells and licensed to Life Technologies

Patrick Farrell, Ph.D.

Over 20 years industry experience as a vaccine and therapeutics developer.

About

Education

University of Calgary

Ph.D., Biochemistry, molecular biology, biochemical engineering / May, 1998

Calgary, Alberta, Canada

University of Calgary

M.Sc, biochemical engineering / May, 1993

Calgary, Alberta, Canada

University of Sydney

B.Eng., Chemical Engineering / November, 1990

Sydney, New South Wales, Australia

Experience

Vista Biologic Solutions Inc

Consultant / March, 2004 — Present

Biologics consultant specializing in early-stage process and analytical development of vaccine and therapeutic products, technology transfer, GMP manufacturing and testing.

Providence Therapeutics

Vice President / September, 2021 — February, 2024

mRNA-LNP Vaccine Process & Analytical Development

Sanofi Pasteur

Senior Director / November, 2019 — August, 2021

Head of Global Bioprocess Technology Platform

Global Director / January, 2007 — October, 2019

Upstream Vaccine Process Development

Nanogen/Suny-X pharma

Head of Research, Development, and Production / January, 2003 — December, 2006

Links & Social Media

Join Patrick on NotedSource!

Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.